Sign inJoin waitlistJoin the waitlist

Andrew Ambrosy

Associate Program Director, Research · Kaiser Permanente Northern California

Credentials: · · · · ·

History

Research · Kaiser Permanente Northern California
Present
Clinical Trials Program · University of California (San Francisco) School of Medicine
Present

Cardiovascular Disease
Duke University Hospital
2014–2017
Internal Medicine
Stanford Health Care
2011–2014
Feinberg School of Medicine
2007–2011

Research

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries
Journal of the American College of Cardiology · 2014 · First of 11 authors · 1,667 citations
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
New England Journal of Medicine · 2019 · 971 citations
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction:…
European Heart Journal · 2013 · First of 15 authors · 498 citations

Javed Butler
61 papers
Stephen Greene
61 papers
Robert Mentz
59 papers · 15 as a fellow
Alan Go
56 papers
MG
Mihai Gheorghiade
52 papers
Marat Fudim
45 papers
Muthiah Vaduganathan
41 papers · 31 as a resident
Ankeet Bhatt
40 papers · 7 as a resident
Sean Collins
29 papers
Adrian Hernandez
26 papers
AS
Alexander Sandhu
23 papers · 23 as a resident
GF
Gregg Fonarow
23 papers

Grants

Infuse Hfpef
National Institute on Aging · R01
PI · $680.8K · Duke University
2026–2031
Deprescribe-Hfpef
National Institute on Aging · R01
PI · $1.4M · Weill Medical Coll of Cornell Univ
2025–2029
Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of AtheroSclerotic CardioVascular Disease (HIDDEN-ASCVD) Study
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.9M · Kaiser Foundation Research Institute
2025–2029
AI-Enabled Echocardiographic Biomarkers and Real-World Data for Predicting Cancer Therapy-Related Cardiac Dysfunction
Food and Drug Administration · U01
PI · $1.5M · Kaiser Foundation Research Institute
2025–2028

Clinical trials

Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
Principal investigator · Enrolling by invitation · Phase 4
Weill Medical College of Cornell University
2026–2029
Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study
Principal investigator · Unknown · Phase 4
Kaiser Permanente
2022–2023